Robotic surgery of the urothelial carcinoma of the upper urinary tract single surgeon initial experience, 66 consecutive cases
- PMID: 39482641
- PMCID: PMC11529183
- DOI: 10.1186/s12894-024-01629-y
Robotic surgery of the urothelial carcinoma of the upper urinary tract single surgeon initial experience, 66 consecutive cases
Abstract
Purpose: Robotic surgery is increasingly utilized in the treatment of urothelial carcinoma of the upper urinary tract (UTUC). This study investigates the advantages and burden of robot-assisted surgical treatment of the urothelial carcinoma of the upper urinary tract in a referral urological department, along with their functional and oncological results.
Methods: The study included 66 prospectively enrolled patients who were surgically treated by a single, robotically specialized surgeon between July 2019 and December 2023. Patients were divided into three groups. Group 1: 50 patients underwent robot-assisted radical Nephroureterectomy (RANU) with bladder cuff excision, Group 2: 11 patients underwent RANU simultaneously with robot-assisted radical cystectomy (RARC), and Group 3: 5 patients underwent robot-assisted segmental ureterectomy (RASU). Clinical and oncological parameters were compared. Perioperative morbidity according to Clavien-Dindo was the primary endpoint of our study. The secondary endpoint was oncologic outcomes.
Results: 37.8% of patients had locally advanced carcinomas. The average console time of RANU with bladder cuff excision was 69 min. The rate of positive surgical margins was n = 1/66 (2%). Lymphadenectomy (LAD) was performed on 30% of patients, with a mean of 13.7 lymph nodes removed. Of those who received LAD, 33% had lymph node metastasis. n = 6/66 (9%) patients received blood transfusion. The overall complication rate was 24%. The readmission rate was 7.5%. With a median follow-up of 26 months, the 2-year recurrence-free survival rate was 84.4%, and the 2-year overall survival rate was 94%.
Conclusion: Robotic surgery is a feasible option for treating UTUC that can be adapted to meet the surgical needs of each patient. Prospective studies are warranted to confirm its benefits.
Keywords: RANU; RARC; Segmental ureterectomy; Upper urinary tract carcinoma (UTUC).
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Surgical benchmarks, mid-term oncological outcomes, and impact of surgical team composition on simultaneous enbloc robot-assisted radical cystectomy and nephroureterectomy.BMC Urol. 2021 Apr 28;21(1):73. doi: 10.1186/s12894-021-00839-y. BMC Urol. 2021. PMID: 33910552 Free PMC article.
-
Is Robotic Superior to Laparoscopic Approach for Radical Nephroureterectomy with Bladder Cuff Excision in Treating Upper Urinary Tract Urothelial Carcinoma?J Endourol. 2023 Feb;37(2):139-146. doi: 10.1089/end.2022.0154. Epub 2022 Nov 18. J Endourol. 2023. PMID: 36267017
-
Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience.World J Urol. 2019 Nov;37(11):2303-2311. doi: 10.1007/s00345-019-02790-y. Epub 2019 May 6. World J Urol. 2019. PMID: 31062121
-
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.Eur Urol Focus. 2019 Mar;5(2):205-223. doi: 10.1016/j.euf.2017.10.003. Epub 2017 Nov 15. Eur Urol Focus. 2019. PMID: 29154042
-
Robot-Assisted Surgery for Upper Tract Urothelial Carcinoma.Urol Clin North Am. 2021 Feb;48(1):71-80. doi: 10.1016/j.ucl.2020.09.011. Epub 2020 Nov 5. Urol Clin North Am. 2021. PMID: 33218595 Review.
References
-
- Rouprêt M, Seisen T, Birtle AJ, Capoun O, Compérat EM, Dominguez-Escrig JL, et al. European Association of Urology Guidelines on Upper urinary tract Urothelial Carcinoma: 2023 update. Eur Urol. 2023;84(1):49–64. - PubMed
-
- Ribal MJ, Huguet J, Alcaraz A. Oncologic outcomes obtained after laparoscopic, robotic and/or single port nephroureterectomy for upper urinary tract tumours. World J Urol. 2013;31(1):93–107. - PubMed
-
- Rassweiler JJ, Schulze M, Marrero R, Frede T, Palou Redorta J, Bassi P. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur Urol. 2004;46(6):690–7. - PubMed
-
- Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T, et al. Oncological outcomes of laparoscopic nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: an European Association of Urology Guidelines Systematic Review. Eur Urol Focus. 2019;5(2):205–23. - PubMed
-
- Melquist JJ, Redrow G, Delacroix S, Park A, Faria EE, Karam JA, et al. Comparison of single-docking robotic-assisted and traditional laparoscopy for Retroperitoneal Lymph Node Dissection during Nephroureterectomy with bladder cuff excision for Upper-tract Urothelial Carcinoma. Urology. 2016;87:216–23. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources